TCL Archive Carter Accepts Upton’s Resignation Effective Dec. 31; DeVita Acting Director; Search Committee Formed December 7, 1979
TCL Archive HCRA Response On DRGs and Clinical Research Threat Called A “Stone Wall,” Legislative Remedy Sought July 27, 1984
TCL Archive Drug Development: Tivozanib Trial Discontinued Due to Insufficient Enrollment February 7, 2014
TCL Archive CMS also decided to cover off-label uses of approved colorectal cancer drugs in clinical trials, and allowed broader use of PET scans. November 5, 2004
